Abstract
The purpose of this study was to investigate the possible roles of the genes functioning in xenobiotic metabolism and antioxidant pathways in the development of severe chronic lung disease in children. Polymorphisms in the genes encoding CYP1A1, CYP2E1, EPHX1, GSTM1, GSTT1, and GSTP1 were investigated in cases of Tatar children with chronic bronchitis (n=129) and relapsing pneumonia (n=50) and in cases of ethnically matched healthy individuals (n=227) living in the city of Ufa, the Republic of Bashkortostan (South Ural region of Russia), by polymerase chain reaction–restriction fragment length polymorphism (PCR-RLFP) method. The frequency of the *2C allele of the CYP1A1 gene was significantly higher in patients than in the healthy control group (χ2=15.02, P=0.0007, Pcor=0.0021). This allele was associated with a higher risk of chronic bronchitis in children (OR 4.14, 95% CI 1.83–9.53; Pcor=0.0024). Similar results were obtained in cases of patients with relapsing pneumonia (OR 3.86, 95% CI 1.34–10.95; Pcor=0.027 for the *2C allele of the CYP1A1 gene). The frequency of the *5B allele of the CYP2E1 gene was higher in the relapsing pneumonia patients (7.0 vs 1.98% in the control group; χ2=5.68, P=0.018, Pcor=0.054; OR 3.72, 95% CI 1.21–11.24). The increase in the GSTT1 gene deletion was significant only in cases of chronic bronchitis (39.53 compared to 21.15% in the control group; χ2=12.96, P=0.001, Pcor=0.003; OR 2.44, 95% CI 1.48–4.04). Our results show that the presence of the GSTM1 gene deletion is unfavorable for the development of chronic lung disease in females (χ2=9.57; P=0.0029, Pcor=0.0116) and was associated with increased risk (OR 2.44, 95% CI 1.36–4.38). The distribution of EPHX1 and GSTP1 gene genotypes was similar in the control and patient groups. Our findings indicate that the polymorphisms of the CYP1A1, CYP2E1, and GSTT1 genes probably play a substantial part in susceptibility to severe airway and lung injury in cases of children with chronic bronchitis and relapsing pneumonia.
Similar content being viewed by others
Abbreviations
- CYP1A1:
-
cytochrome P-4501A1
- CYP2E1:
-
cytochrome P-4502E1
- GSTM1:
-
Glutathione S-transferase
- GSTT1:
-
Glutathione S-transferase T1
- GSTP1:
-
Glutathione S-transferase
- EPHX1:
-
Microsomal epoxide hydrolase
References
American Thoracic Society Documents (2003) Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 168:356–396
Preston JA, Beagley KW, Gibson PG, Hansbro PM (2004) Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia. Eur Respir J 23:224–231
Stick S (2000) Paediatric origins of adult lung disease 1. The contribution of airway development to paediatric and adult disease. Thorax 55:587–594
National Heart, Lung and Blood Institute (1995) National Institutes of Health. Global initiative for asthma. Global strategy for asthma management and prevention NHLB/WHO workshop report. http://www.ginasthma.com/workshop/default.html
Sly PD (2000) Paediatric origins of adult lung disease. Introduction. Thorax 55:585–586
Silverman EK, Palmer LJ (2000) Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22:645–648
Forsberg L, Faire U, de Morgenstern R (2001) Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389(1):84–93
Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E (2004) Glutathione S-transferase deficiency and passive smoking increase childhood asthma. Thorax 59(7):569–573
Hall I (2002) Candidate gene studies in respiratory disease: avoiding the pitfalls. Thorax 57:377–378
Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, Mouraire P, Riol N, Malet P (1997) Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 99(6):822–826
Koyama H, Gedders D (1998) Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax 53:510–514
Smith CAD, Harrison DJ (1997) Association between polymorphism in the gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630–633
He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ (2004) Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 170(4):388–394
Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L (2002) Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 166(5):710–716
Ivaschenko TE, Sideleva OG, Baranov VS (2002) Glutathione–S-transferase mu and theta gene polymorphisms as new risk factors of atopic bronchial asthma. J Mol Med 80(1):39–43
Gauderman WJ, McConnell R, Gilliland F, London S, Thomas D, Avol E, Vora H, Berhane K, Rappaport EB, Lurmann F, Margolis HG, Peters J (2000) Association between air pollution and lung function growth in southern California children. Am J Respir Crit Care Med 162(4 Pt 1):1383–1390
Jourenkova-Mironova N, Wikman H, Bouchardy C, Voho A, Dayer P, Benhamou S, Hirvonen A (1998) Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics 8(6):495–502
Smith GB, Harper PA, Wong JM, Lam MS, Reid KR, Petsikas D, Massey TE (2001) Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol Biomark Prev 10(8):839–853
Ioannides C (2001) Enzymes systems that metabolise drugs and other xenobiotics. Wiley, UK, p 567
Oyama T, Mitsudomi T, Kawamoto T, Ogami A, Osaki T, Kodama Y, Yasumoto K (1995) Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 67(4):253–256
Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3–28
Hildebrand CE, Gonzalez FJ, McBride OW, Nebert DW (1985) Assignment of the human 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 gene to chromosome 15. Nucleic Acids Res 13:2009–2016
Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic polymorphisms of the lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450A1 gene. J Biochem 110:407–411
Croft F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15:2961–2963
Huang CY, Huang KL, Cheng TJ, Wang JD, Hsieh LL (1997) The GSTT1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function. Arch Toxicol 71:482–488
Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450 IIE1 gene. J Biochem 100:559–564
Kolble K (1993) Regional mapping of short tandem repeats on human chromosome 10: cytochrome P450 gene CYP2E, D10S196, D10S220, and D10S225. Genomics 18:702–704
Okino ST, Quattrochi LC, Pendurthi UR, McBride OW, Tukey YRH (1987) Characterization of multiple human cytochrome P-450 1 cDNAs: the chromosomal localization of the gene and evidence for alternate RNA splicing. J Biol Chem 262:16072–16079
International statistical classification of diseases and related health problems. Tenth revision. ICD-10 (1992). World Health Organization, Geneva
Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning—a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor
Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles. http://www.imm.ki.se/CYPalleles/
Swofford L, Selander B (1997) BIOSYS-2: computer program for the analysis of allelic variation in genetics. University of Illinois, USA (current release)
Schlesselman J (1982) Case-control studies. Design, conduct, analysis. Oxford University Press, Oxford, pp 58–96
StatSoft Inc., USA. Statistica v. 6.0. http://www.statistica.com
Korytina GF, Yanbaeva DG, Victorova TV (2003) Polymorphisms of the cytochrome P450 (CYP1A1, CYP2E1) and microsomal epoxide hydrolase (mEPHX) genes in cystic fibrosis and chronic respiratory disease. Mol Biol (Mosk) 37(5):784–792
Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59:3317–3320
Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML (2000) Gender differences in genetic susceptibility for lung cancer. Lung Cancer 30:153–160
Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kesley KT (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69
Acknowledgements
This work was supported by the Russian Foundation for Basic Research (grant 04-04-48318a), the Russian Scientific Foundation for Humanities (04-06-00016a) and the Russian Federation President Program (grant Mκ-2755.2004). We would like to express our gratitude to the families of patients who participated in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korytina, G.F., Yanbaeva, D.G., Babenkova, L.I. et al. Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children. J Mol Med 83, 700–710 (2005). https://doi.org/10.1007/s00109-005-0660-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-005-0660-6